You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prednisolone

Showing 51 - 75 of 1,775
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Dose Prednisolone Pharmacokinetics in Acute and Chronic

Not yet recruiting
  • Thyroid Eye Disease
  • +4 more
  • No intervention - prednisolone is taken as part if routine clinical care.
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Aug 11, 2021

Hypoglycaemia (Low Blood Sugar) in Diabetes and Adrenal Failure

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +2 more
  • Continuous Glucose Monitoring
  • London, United Kingdom
    Charing Cross Hospital, Imperial College Healthcare NHS Trust
Apr 13, 2023

Infantile Spasm, West Syndrome Trial in Ratchathewi (Combination therapy with vigabatrin and prednisolone, Vigabatrin Tablets)

Recruiting
  • Infantile Spasm
  • West Syndrome
  • Combination therapy with vigabatrin and prednisolone
  • Vigabatrin Tablets
  • Ratchathewi, Bangkok, Thailand
    Queen Sirikit National Institute of Child Health
Aug 24, 2021

Pterygium Trial in New York (Dexamethasone Intracanalicular Insert, 0.4mg, Prednisolone Acetate 1%)

Completed
  • Pterygium
  • Dexamethasone Intracanalicular Insert, 0.4mg
  • Prednisolone Acetate 1%
  • New York, New York
    New York Eye Specialists
Apr 4, 2022

Cataract Surgery, Glaucoma Surgery Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Ophthalmic Suspension [PRED

Withdrawn
  • Cataract Surgery
  • Glaucoma Surgery
  • Dextenza 0.4Mg Ophthalmic Insert
  • Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]
  • (no location specified)
Nov 16, 2021

Cataract Diabetic, Macula Edema Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)

Not yet recruiting
  • Cataract Diabetic
  • Macula Edema
  • Dextenza 0.4Mg Ophthalmic Insert
  • Prednisolone Acetate 1% Oph Susp
  • (no location specified)
Jul 15, 2021

Arterial Ischemic Stroke Trial in France (Methylprednisolone + prednisolone)

Withdrawn
  • Arterial Ischemic Stroke
  • Methylprednisolone + prednisolone
  • (no location specified)
Oct 17, 2022

Smell Loss Trial in Minya (Prednisolone)

Recruiting
  • Smell Loss
  • Prednisolone
  • Minya, المنيا, Egypt
    Soad A. Mohamad
Oct 20, 2022

Nasal Polyps, Chronic Rhinosinusitis With Nasal Polyps Trial (Doxycycline 100 mg Oral Tablet, Prednisolone 20 mg)

Not yet recruiting
  • Nasal Polyps
  • Chronic Rhinosinusitis With Nasal Polyps
  • Doxycycline 100 mg Oral Tablet
  • Prednisolone 20 mg
  • (no location specified)
Jan 24, 2022

Root Canal Obturation Trial in France (root canal sealer : CORTISOMOL SP, root canal sealer : SEALITE REGULAR)

Completed
  • Root Canal Obturation
  • root canal sealer : CORTISOMOL SP
  • root canal sealer : SEALITE REGULAR
  • Lamballe, France
  • +7 more
Feb 14, 2022

Medication Overuse Headache Trial in Ankara (Intravenous hydration, Intravenous prednisolone, Intravenous lidocaine)

Active, not recruiting
  • Medication Overuse Headache
  • Intravenous hydration
  • +2 more
  • Ankara, Turkey
    Diskapi Yildirim Beyazıt Teaching and Research Hospital
Nov 2, 2022

Inflammatory Cardiomyopathy Trial in Germany (Mycophenolate Mofetil, Prednisolone, Mycophenolate Mofetil Placebo)

Not yet recruiting
  • Inflammatory Cardiomyopathy
  • Mycophenolate Mofetil
  • +3 more
  • Bad Nauheim, Germany
  • +9 more
Oct 5, 2022

IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)

Recruiting
  • IgG4-related Disease With Eosinophilia
  • Beijing, Bejing, China
    Peking Union Medical College Hospital
Mar 23, 2023

Colitis Trial in Aalborg, Odense, London (Infliximab, Methylprednisolone, Prednisolone)

Not yet recruiting
  • Colitis
  • Aalborg, Denmark
  • +2 more
Jul 7, 2023

DLBCL Trial (Sintilimab, Rituximab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • (no location specified)
Mar 6, 2022

Metastatic Castration-resistant Prostate Cancer Trial (Niraparib plus Abiraterone Acetate (Nira/AA) combination,

Available
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Aug 24, 2022

Steroid-Sensitive Nephrotic Syndrome Trial in Shanghai (Rituximab, Corticosteroid)

Not yet recruiting
  • Steroid-Sensitive Nephrotic Syndrome
  • Shanghai, Shanghai, China
  • +2 more
May 6, 2023

Focal Cerebral Arteriopathy, Pediatric Stroke, Arteriopathy Trial in San Francisco (methylprednisolone, prednisolone,

Not yet recruiting
  • Focal Cerebral Arteriopathy
  • +3 more
  • methylprednisolone, prednisolone, prednisone
  • San Francisco, California
    University of California San Francisco
Sep 8, 2023

Glaucoma Trial in Bronx (Pilocarpine, Prednisolone, Ofloxacin)

Enrolling by invitation
  • Glaucoma
  • Bronx, New York
  • +1 more
Sep 16, 2022

Minimal Change Disease Trial in London (tacrolimus, prednisolone)

Completed
Has Results
  • Minimal Change Disease
  • London, United Kingdom
    Hammersmith Hospital
Apr 9, 2021

Crohn Disease, Nutrient; Excess, Remission/Regression Trial in Duzce (EEN (Nestle Modulen®), Standart of care)

Recruiting
  • Crohn Disease
  • +2 more
  • EEN (Nestle Modulen®)
  • Standart of care
  • Duzce, Turkey
    Duzce University School of Medicine
Oct 15, 2022

Glaucoma, Cataract Trial in Bronx (Dexamethasone Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)

Recruiting
  • Glaucoma
  • Cataract
  • Dexamethasone Ophthalmic Insert
  • Prednisolone Acetate 1% Oph Susp
  • Bronx, New York
    The New York Eye Surgery Center
Mar 20, 2022

Prostatic Tumors Trial in Worldwide (EPI-7386, Abiraterone Acetate, Prednisone or Prednisolone)

Suspended
  • Prostatic Neoplasms
  • Towson, Maryland
  • +3 more
Nov 3, 2022

Hearing Loss, Sensorineural Trial in Halle (Saale) (AC102 gel, Prednisolone, Placebo Tablets)

Recruiting
  • Hearing Loss, Sensorineural
  • AC102 gel
  • +3 more
  • Halle (Saale), Germany
    Clinical Trial Site
Mar 24, 2023

Immune Mediated Inflammatory Diseases Trial in Leiden (BAY1834845, BAY1830839, Prednisolone)

Completed
  • Immune Mediated Inflammatory Diseases
  • Leiden, Netherlands
    Center for Human Drug Research
Dec 15, 2022